BHAVANA JODHA

About

A senior PhD candidate specializing in cancer nanomedicine, with a research focus on nanovesicle‑based drug delivery systems for targeted therapy in breast cancer. My doctoral work centers on preparing cell‑derived nanovesicles as biomimetic carriers to enhance tumor selectivity, improve intracellular delivery, and reduce off‑target toxicity of chemotherapeutic agents.

Expertise encompasses advanced mammalian cell culture (including maintenance of cancer cell lines, development of 2D/3D in vitro models), functional cytotoxicity assays (MTT/XTT, clonogenic assays, apoptosis analysis, LDH Release) and molecular biology techniques for core protein and gene expression analysis (Western Blot and qRT-PCR).

Parallelly developed a background in nanotechnology, including the synthesis of inorganic and organic nanoparticles, surface functionalization, drug loading, and comprehensive physicochemical characterization of nanoparticles (NTA, DLS, zeta potential, TEM, SEM, drug loading/release kinetics).

My broader interests lie in translational nanomedicine, extracellular vesicle‑inspired systems, and cell‑based drug delivery strategies for breast cancer and immuno‑oncology.

I actively collaborate in multidisciplinary teams, contribute to manuscript preparation and conference presentations, and aim to bridge fundamental nanoscience with clinically relevant cancer therapeutics.

Employment

Employment history is unavailable.

Education

• Central University of Gujarat PhD. Life Sciences
  2019 - Present
• Central University of Punjab MSc. Life Sciences
  2017 - 2019
• University of Rajasthan BSc. Hons.
  2014 - 2017

Projects & Funding

Projects & funding information is unavailable.

Publications (8)

• Nanotechnological aspects in the development of phyto-therapeutics against metabolic disorders
  Plant-Based Drug Discovery 2026 DOI: 10.1016/b978-0-443-31698-2.00014-x
  +Save
• Monoamine neurotransmitter functionalized poly(amidoamine) dendrimers for targeting of cabazitaxel to human prostate cancer cells
  Discover Nano 2025 DOI: 10.1186/s11671-025-04368-7
  +Save
• Glycyrrhizic Acid‐Based Self‐Targeted Nanomicelles for the Delivery of Gefitinib to PKCα Receptor Overexpressing Cancer Cells
  Particle & Particle Systems Characterization 2025 DOI: 10.1002/ppsc.202400217
  +Save
• Enhancing apoptosis-mediated anticancer activity of evodiamine through protein-based nanoparticles in breast cancer cells
  Scientific Reports 2024 DOI: 10.1038/s41598-024-51970-3
  +Save
• Folate conjugated albumin as a targeted nanocarrier for the delivery of fisetin: in silico and in vitro biological studies
  RSC Advances 2024 DOI: 10.1039/d3ra08434e
  +Save
• Therapeutic Phytoconstituents-II
  Nanotechnology Based Delivery of Phytoconstituents and Cosmeceuticals 2024 DOI: 10.1007/978-981-99-5314-1_3
  +Save
• Trehalose and its Diverse Biological Potential
  Current Protein & Peptide Science 2023 DOI: 10.2174/1389203724666230606154719
  +Save
• Recent advances in phytochemical based nano-drug delivery systems to combat breast cancer: A review
  Journal of Drug Delivery Science and Technology 2022 DOI: 10.1016/j.jddst.2022.103832
  +Save